ScholarIQanswers from OpenAlex

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition

PaperCitations, authors & open-access status

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition have?

ScholarIQcitation count

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition has 3 citations in the OpenAlex counts ScholarIQ stores.

When was Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition published?

ScholarIQyear

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition has 2025 year in the ScholarIQ index.

What is the open-access status of Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition?

ScholarIQoa status

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition has gold oa status in the ScholarIQ index.

What is the DOI of Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition?

ScholarIQdoi

The DOI for Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition is on the source record.

What is the PMID of Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition?

ScholarIQpmid

The PMID for Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition is on the source record.

What is the OpenAlex record for Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition?

ScholarIQopenalex

The OpenAlex for Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial